Choosing between CAR T-cell therapy and pirtobrutinib in double-refractory CLL.

Saved in:
Bibliographic Details
Title: Choosing between CAR T-cell therapy and pirtobrutinib in double-refractory CLL.
Authors: Rogers KA; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio.
Source: Clinical advances in hematology & oncology : H&O [Clin Adv Hematol Oncol] 2024 Dec; Vol. 22 (10), pp. 494-496.
Publication Type: Interview
Journal Info: Publisher: Millennium Medical Pub Country of Publication: United States NLM ID: 101167661 Publication Model: Print Cited Medium: Internet ISSN: 1543-0790 (Print) Linking ISSN: 15430790 NLM ISO Abbreviation: Clin Adv Hematol Oncol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1543-0790